MHRA Phase I Accreditation Certificate (October 2023)
The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.
MHRA Phase I Accreditation Certificate (01 June 2022)
The accreditation is based on the Unit continuing to maintain satisfactory standards for avoiding harm to trial subjects and for handling medical emergencies should they arise.
Richmond Pharmacology Appoints Dr Daniel Chapple as Commercial Director
July 13, 2026
Richmond Pharmacology, the London-based contract research organisation and global leader in early phase clinical trials, announces the appointment of Dr Daniel Chapple PhD FCIM as Commercial Director.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
